A citation-based method for searching scientific literature

C Julian-Reynier, F Eisinger, P Vennin, F Chabal, Y Aurran, C Noguès, Y J Bignon, M Machelard-Roumagnac, C Maugard-Louboutin, D Serin, B Blanc, P Orsoni, H Sobol. J Med Genet 1996
Times Cited: 100







List of co-cited articles
738 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Attitudes about genetic testing for breast-ovarian cancer susceptibility.
C Lerman, M Daly, A Masny, A Balshem. J Clin Oncol 1994
434
59

Interest in genetic testing among first-degree relatives of breast cancer patients.
C Lerman, J Seay, A Balshem, J Audrain. Am J Med Genet 1995
263
51

Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families.
J P Struewing, C Lerman, R G Kase, T R Giambarresi, M A Tucker. Cancer Epidemiol Biomarkers Prev 1995
184
40

BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
C Lerman, S Narod, K Schulman, C Hughes, A Gomez-Caminero, G Bonney, K Gold, B Trock, D Main, J Lynch,[...]. JAMA 1996
604
37

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
36


Decision-making about genetic testing among women at familial risk for breast cancer.
P B Jacobsen, H B Valdimarsdottier, K L Brown, K Offit. Psychosom Med 1997
127
32

Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995
26


Women's receptivity to testing for a genetic susceptibility to breast cancer.
H Chaliki, S Loader, J C Levenkron, W Logan-Young, W J Hall, P T Rowley. Am J Public Health 1995
128
23

Psychological responses to BRCA1 mutation testing: preliminary findings.
R T Croyle, K R Smith, J R Botkin, B Baty, J Nash. Health Psychol 1997
243
22

Mammography adherence and psychological distress among women at risk for breast cancer.
C Lerman, M Daly, C Sands, A Balshem, E Lustbader, T Heggan, L Goldstein, J James, P Engstrom. J Natl Cancer Inst 1993
352
21

Family Communication and Genetic Counseling: The Case of Hereditary Breast and Ovarian Cancer.
J Green, M Richards, F Murton, H Statham, N Hallowell. J Genet Couns 1997
122
21

Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.
C Lerman, B Biesecker, J L Benkendorf, J Kerner, A Gomez-Caminero, C Hughes, M M Reed. J Natl Cancer Inst 1997
276
21

Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer.
M Cappelli, L Surh, L Humphreys, S Verma, D Logan, A Hunter, J Allanson. Clin Genet 1999
92
22


Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude,[...]. Am J Hum Genet 1998
20

A common region of 10p deleted in DiGeorge and velocardiofacial syndromes.
S C Daw, C Taylor, M Kraman, K Call, J Mao, S Schuffenhauer, T Meitinger, T Lipson, J Goodship, P Scambler. Nat Genet 1996
149
20

Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: implications for genetic counselling and prenatal diagnosis.
D A Driscoll, J Salvin, B Sellinger, M L Budarf, D M McDonald-McGinn, E H Zackai, B S Emanuel. J Med Genet 1993
406
20


Molecular definition of 22q11 deletions in 151 velo-cardio-facial syndrome patients.
C Carlson, H Sirotkin, R Pandita, R Goldberg, J McKie, R Wadey, S R Patanjali, S M Weissman, K Anyane-Yeboa, D Warburton,[...]. Am J Hum Genet 1997
291
20

Impact of Event Scale: a measure of subjective stress.
M Horowitz, N Wilner, W Alvarez. Psychosom Med 1979
19

Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium.
W Burke, M Daly, J Garber, J Botkin, M J Kahn, P Lynch, A McTiernan, K Offit, J Perlman, G Petersen,[...]. JAMA 1997
697
19

Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington.
S J Durfy, D J Bowen, A McTiernan, J Sporleder, W Burke. Cancer Epidemiol Biomarkers Prev 1999
145
18



Disclosure to the family of breast/ovarian cancer genetic test results: patient's willingness and associated factors.
C Julian-Reynier, F Eisinger, F Chabal, C Lasset, C Noguès, D Stoppa-Lyonnet, P Vennin, H Sobol. Am J Med Genet 2000
77
22

Psychological distress and surveillance behaviors of women with a family history of breast cancer.
K M Kash, J C Holland, M S Halper, D G Miller. J Natl Cancer Inst 1992
432
16

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
D Ford, D F Easton, D T Bishop, S A Narod, D E Goldgar. Lancet 1994
16

A descriptive study of BRCA1 testing and reactions to disclosure of test results.
H T Lynch, S J Lemon, C Durham, S T Tinley, C Connolly, J F Lynch, J Surdam, E Orinion, S Slominski-Caster, P Watson,[...]. Cancer 1997
169
16

Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients.
Erna Claes, Gerry Evers-Kiebooms, Andrea Boogaerts, Marleen Decruyenaere, Lieve Denayer, Eric Legius. Am J Med Genet A 2003
163
16

Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.
R Wooster, S L Neuhausen, J Mangion, Y Quirk, D Ford, N Collins, K Nguyen, S Seal, T Tran, D Averill. Science 1994
15


Clinical findings with implications for genetic testing in families with clustering of colorectal cancer.
J T Wijnen, H F Vasen, P M Khan, A H Zwinderman, H van der Klift, A Mulder, C Tops, P Møller, R Fodde. N Engl J Med 1998
310
14

Genetic testing for cancer risk: a population survey on attitudes and intention.
Cornelia M Ulrich, Alan R Kristal, Emily White, Julie R Hunt, Sharon J Durfy, John D Potter. Community Genet 1998
50
28

Awareness and attitudes concerning BRCA gene testing.
A Mogilner, M Otten, J D Cunningham, S T Brower. Ann Surg Oncol 1998
48
29

To tell or not to tell: barriers and facilitators in family communication about genetic risk.
K Forrest, S A Simpson, B J Wilson, E R van Teijlingen, L McKee, N Haites, E Matthews. Clin Genet 2003
244
14

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.
J P Struewing, P Hartge, S Wacholder, S M Baker, M Berlin, M McAdams, M M Timmerman, L C Brody, M A Tucker. N Engl J Med 1997
13

BRCA1 in the family: a case description of the psychological implications.
A C DudokdeWit, A Tibben, P G Frets, E J Meijers-Heijboer, P Devilee, J G Klijn, J C Oosterwijk, M F Niermeijer. Am J Med Genet 1997
67
17

Linkage of early-onset familial breast cancer to chromosome 17q21.
J M Hall, M K Lee, B Newman, J E Morrow, L A Anderson, B Huey, M C King. Science 1990
12

BRCA1 and BRCA2: from molecular genetics to clinical medicine.
M A Blackwood, B L Weber. J Clin Oncol 1998
133
12

Psychological risks of genetically testing children for a hereditary cancer syndrome.
F J Grosfeld, C J Lips, F A Beemer, H G van Spijker, G J Brouwers-Smalbraak, H F ten Kroode. Patient Educ Couns 1997
27
44

Psychological side effects of breast cancer screening.
C Lerman, B Trock, B K Rimer, C Jepson, D Brody, A Boyce. Health Psychol 1991
398
12

Genetic counseling and testing for breast-ovarian cancer susceptibility: what do women want?
J Audrain, B Rimer, D Cella, J Garber, B N Peshkin, J Ellis, J Schildkraut, M Stefanek, V Vogel, C Lerman. J Clin Oncol 1998
67
17

Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk.
C Hughes, A Gomez-Caminero, J Benkendorf, J Kerner, C Isaacs, J Barter, C Lerman. Patient Educ Couns 1997
163
12


All in the family: evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results.
Chanita Hughes, Caryn Lerman, Marc Schwartz, Beth N Peshkin, Lari Wenzel, Steven Narod, Camille Corio, Kenneth P Tercyak, Danielle Hanna, Claudine Isaacs,[...]. Am J Med Genet 2002
156
12



Predictive testing for Huntington's disease: risk perception, reasons for testing and psychological profile of test applicants.
M Decruyenaere, G Evers-Kiebooms, A Boogaerts, J J Cassiman, T Cloostermans, K Demyttenaere, R Dom, J P Fryns, H Van den Berghe. Genet Couns 1995
69
15


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.